甲状腺癌
CXCR4型
转移
癌症研究
巨噬细胞移动抑制因子
甲状腺
细胞
生物
淋巴结
医学
免疫系统
病理
癌症
内科学
免疫学
内分泌学
细胞因子
趋化因子
遗传学
作者
Wei Chen,Xinnian Yu,Huixin Li,Shenglong Yuan,Yuqi Fu,Huanhuan Hu,Fangzhou Liu,Yuan Zhang,Shanliang Zhong
出处
期刊:Oral Oncology
[Elsevier]
日期:2023-12-06
卷期号:148: 106654-106654
被引量:1
标识
DOI:10.1016/j.oraloncology.2023.106654
摘要
The mechanism promoting papillary thyroid carcinoma (PTC) metastasis remains unclear. We aimed to investigate the potential metastatic mechanisms at a single-cell resolution. We performed single-cell RNA-seq (scRNA-seq) profiling of thyroid tumour (TT), adjacent normal thyroid (NT) and lymph node metastasized tumour (LN) from a young female with PTC. Validation of our results was conducted in 31 tumours with metastasis and 30 without metastasis. ScRNA-seq analysis generated data on 38,215 genes and 0.14 billion transcripts from 28,839 cells, classified into 18 clusters, each annotated to represent 10 cell types. PTC cells were found to originate from epithelial cells. Epithelial cells and macrophages emerged as the strongest signal emitters and receivers, respectively. After reclustering epithelial cells and macrophages, our analysis, incorporating gene set variation analysis (GSVA), SCENIC analysis, and pseudotime trajectory analysis, indicated that subcluster 0 of epithelial cells (EP_0) showed a more malignant phenotype, and subclusters 3 and 4 of macrophages (M_3 and M_4) demonstrated heightened activity. Further analysis suggested that EP_0 may suppress the activity of M_3 and M_4 via MIF − (CD74 + CXCR4) in the MIF pathway. After analysing the expression of the 4 genes in the MIF pathway in both the TCGA cohort and our cohort (n = 61), CD74 was identified as significantly overexpressed in PTC tumours particularly those with lymph node metastasis. Our study revealed that PTC may facilitate lymph node metastasis by inhibiting macrophages via MIF signalling. It is suggested that malignant PTC cells may suppress the immune activity of macrophages by consistently releasing signals to them via MIF−(CD74 + CXCR4).
科研通智能强力驱动
Strongly Powered by AbleSci AI